Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sundrug CoSDGCF 75 Days Sales Outstanding is 13.01 as of Jun. 2026, which is 29% above its 10-year median of 10.06. GuruFocus rates SDGCF with a GF Score™ of 75/100 and a GF Value™ of $36.82. The stock has 1 warning sign investors should review. Among 664 Healthcare Providers & Services companies, Sundrug Co ranks better than 88.7% on this metric.
Sundrug Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was $193 Mil. Sundrug Co's Revenue for the
three
months ended in Jun. 2026 was $1,351 Mil.
Hence, Sundrug Co's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 13.01.
The historical rank and industry rank for Sundrug Co's Days Sales Outstanding or its related term are showing as below:
SDGCF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.96 Med: 10.06 Max: 13.5
Current: 12.94
During the past 13 years, Sundrug Co's highest Days Sales Outstanding was 13.50. The lowest was 4.96. And the median was 10.06.
SDGCF's Days Sales Outstanding is ranked better than 88.7% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs SDGCF: 12.94
Sundrug Co's Days Sales Outstanding
increased
from Jun. 2025 (12.67) to Jun. 2026 (13.01).
Sundrug Co (OTCPK:SDGCF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Sundrug Co Days Sales Outstanding Related Terms
Sundrug Co Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co Days Sales Outstanding Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sundrug Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co (SDGCF) has a Days Sales Outstanding of 13.01 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sundrug Co and its competitors. This is 29% above median its historical median of 10.06. Over the past decade, Sundrug Co's Days Sales Outstanding has ranged from 4.96 to 13.50. According to the industry distribution chart, Sundrug Co ranks #75 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 11.3%.
Is Sundrug Co's Days Sales Outstanding too high?
Sundrug Co's current Days Sales Outstanding of 13.01 is 29% above median its 10-year median of 10.06. Over the past 10 years, this metric has ranged from a low of 4.96 to a high of 13.50. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. Sundrug Co's value of 13.01 is 71.6% below this industry median. Based on the distribution chart, Sundrug Co ranks #75 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sundrug Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Days Sales Outstanding compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #75 out of 664 companies for Days Sales Outstanding. This places Sundrug Co in the top 11% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.78. Sundrug Co's value of 13.01 is 71.6% below this benchmark. Historically, Sundrug Co's own Days Sales Outstanding has ranged from 4.96 to 13.50 over the past decade. While the company's 10-year median is 10.06 vs. the industry median of 45.78, Sundrug Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Days Sales Outstanding of 13.01 is 71.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Days Sales Outstanding is 13.01, which is 29% above median its own 10-year median of 10.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current Days Sales Outstanding of 13.01. The stock's GF Value™ is $36.82, compared to a current price of $28.18 — trading 23.5% below its estimated fair value. The current Days Sales Outstanding is 13.01, which is 29% above median its 10-year median of 10.06 and 71.6% below the Healthcare Providers & Services industry median of 45.78. Sundrug Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current Days Sales Outstanding is 13.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 23.5% below its estimated GF Value™ of $36.82.
Key valuation signals for SDGCF:
Days Sales Outstanding: 13.01 (29% above median its 10-year median of 10.06)
GF Value™: $36.82 vs. price of $28.18 (23.5% below fair value)
Industry Position: 71.6% below the Healthcare Providers & Services median (#75 of 664)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
75GF Score
Get the complete analysis for SDGCF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 
